Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases, and impact on survival

Bae SS, Rivero Gallegos D, Bozan F, Sambataro G, Dourado E, Zanframundo G, Ventura IB, Yoshida A, Faghihi-Kashani S, Loganathan A, Bonella F, Gonzalez-Gay MA, Kuwana M, Oddis CV, Rojas-Serrano J, Gupta L, Rathore U, Anuja A, Fornaro M, Iannone F, Bianchessi L, Shinjo SK, de Souza FHC, Miossi R, Luppi F, Moghadam-Kia S, Aggarwal R, Cavagna L; CLASS project participating investigators. Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases, and impact on survival. Rheumatology (Oxford). 2026 Sep 29:keag543. doi: 10.1093/rheumatology/keag543. Epub ahead of print. PMID: 42809241.


Related Posts